Cargando…
Blood HDAC4 Variation Links With Disease Activity and Response to Tumor Necrosis Factor Inhibitor and Regulates CD4+ T Cell Differentiation in Ankylosing Spondylitis
PURPOSE: Histone deacetylase 4 (HDAC4) regulates the progression of autoimmune diseases. This study aimed to further investigate the correlation between HDAC4 and Th cells, inflammation, disease activity, and treatment response in patients with ankylosing spondylitis (AS). METHODS: A total of 132 ac...
Autores principales: | Dou, Bin, Ma, Fuzhe, Jiang, Zhenyu, Zhao, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121817/ https://www.ncbi.nlm.nih.gov/pubmed/35602496 http://dx.doi.org/10.3389/fmed.2022.875341 |
Ejemplares similares
-
The impact of smoking status on radiographic progression in patients with ankylosing spondylitis on anti-tumor necrosis factor treatment
por: Nam, Bora, et al.
Publicado: (2022) -
Gout in the Chest Misdiagnosed as Ankylosing Spondylitis
por: Xue, Wenjing, et al.
Publicado: (2020) -
Thoracic Discitis in Ankylosing Spondylitis
por: Maloney, Eamon, et al.
Publicado: (2018) -
Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Ankylosing Spondylitis
por: Perpétuo, Inês P., et al.
Publicado: (2015) -
The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis
por: Lee, Suhwan, et al.
Publicado: (2019)